Adagene-adr Share Price Today
(NASDAQ: ADAG)

Name: Adagene-adr Share Price (NASDAQ: ADAG) - Stock Quote, Live Chart
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Adagene-adr share price is $1.55 & ₹130.79 as on 3 May 2025, 2.30 'hrs' IST

$1.55

▲

-0.03

(-1.9%)

Market is closed - opens 7 PM, 05 May 2025

View live Adagene-adr share price in Dollar and Rupees. Guide to invest in Adagene-adr stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Adagene-adr, along with analyst recommendations, forecasts, and comprehensive financials.

Adagene-adr share price movements

Today's Low: $1.55
Today's High: $1.60
$1.55
0.0%
Downside
Day's Volatility :3.13%
Upside
3.13%
52 Weeks Low: $1.33
52 Weeks High: $3.58
$1.55
14.52%
Downside
52 Weeks Volatility :63.0%
Upside
56.71%

Adagene-adr (ADAG) Returns

Period	Adagene Inc-adr	Sector (Health Care)	Index (Russel 2000)
3 Months	-18.85%	-5.8%	0.0%
6 Months	-49.18%	-5.6%	0.0%
1 Year	-32.9%	-1.7%	0.0%
3 Years	-55.71%	4.3%	-9.3%

Adagene-adr (ADAG) Key Statistics

in dollars & INR

Previous Close	$1.58
Open	$1.6
Today's High	$1.6
Today's Low	$1.55
Market Capitalization	$71.6M
Today's Volume	$3.8K
52 Week High	$3.5807
52 Week Low	$1.325
Revenue TTM	$103.2K
EBITDA	$-35.2M
Earnings Per Share (EPS)	$-0.74
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-55.21%

How to invest in Adagene-adr Stock (ADAG) from India?

It is very easy for Indian residents to invest directly in Adagene-adr from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Adagene-adr stock in both Indian Rupees (INR) and US Dollars (USD). Search for Adagene-adr or ADAG on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Adagene-adr or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Adagene-adr shares which would translate to 0.544 fractional shares of Adagene-adr as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Adagene-adr, in just a few clicks!

Returns in Adagene-adr (ADAG) for Indian investors in Rupees

The Adagene-adr stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Adagene-adr investment value today

Current value as on today

₹68,272

Returns

₹31,728

(-31.73%)

Returns from Adagene-adr Stock

₹32,900 (-32.9%)

Dollar Returns

₹1,172 (+1.17%)

Indian investors sentiment towards Adagene-adr (ADAG)

-10%

Period: Apr 3, 2025 to May 3, 2025. Change in 30 Days versus previous period

Search interest for Adagene-adr Stock from India on INDmoney has decreased by -10% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Adagene-adr

Wuxi AppTec Co Ltd
8.45%
General Atlantic Llc
8.12%
Fidelity International Ltd
6.95%
SC China Holding Ltd
2.85%
FMR Inc
2.74%
Mill Creek Capital Advisors LLC
0.42%

Analyst Recommendation on Adagene-adr

Rating

Trend

Buy

87%Buy

12%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Adagene-adr(by analysts ranked 0 to 5 stars)

Analyst Forecast on Adagene-adr Stock (ADAG)

What analysts predicted

Upside of 557.21%

Target:

$10.19

Current:

$1.55

Insights on Adagene-adr Stock (Ticker Symbol: ADAG)

Price Movement
In the last 7 days, ADAG stock has moved up by 9.2%
Decreasing Revenue
Revenue is down for the last 4 quarters, 8.64M → 407.87K (in $), with an average decrease of 31.8% per quarter
Decreasing Net Profit
Netprofit is down for the last 6 quarters, -2.05M → -8.50M (in $), with an average decrease of 55.2% per quarter
ADAG vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.2% return, outperforming this stock by 105.9%
ADAG vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 80.7% return, outperforming this stock by 137.2%
Price to Sales
ForADAG every $1 of sales, investors are willing to pay $775.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Adagene-adr Technicals Summary

Sell

Neutral

Buy

Adagene-adr is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Adagene-adr (ADAG) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Adagene Inc-adr	-1.94%	-49.18%	-32.9%	-55.71%	-89.07%
Regeneron Pharmaceuticals, Inc.	5.59%	-26.95%	-36.84%	-5.3%	5.42%
Beone Medicines Ltd	7.16%	23.32%	57.31%	60.26%	78.11%
Vertex Pharmaceuticals Incorporated	5.59%	6.0%	24.51%	88.14%	84.02%
Alnylam Pharmaceuticals, Inc.	9.96%	-3.97%	71.43%	89.58%	83.55%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Adagene Inc-adr	NA	NA	NA	-0.83	-0.55	-0.22	NA	1.07
Regeneron Pharmaceuticals, Inc.	15.94	15.94	0.91	39.38	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.1	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.38	17.94	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.44	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Adagene Inc-adr	Buy	$71.6M	-89.07%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$66.5B	5.42%	15.94	31.07%
Beone Medicines Ltd	NA	$28.2B	78.11%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$128.2B	84.02%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$33.0B	83.55%	NA	-12.37%

About Adagene-adr

Adagene Inc., a clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People's Republic of China. Its lead product candidate is the ADG126, a masked fully-human anti-CTLA-4 mAb which is in phase 1b/2 clinical development for the treatment of cancer. The company also develops ADG116, a fully human anti-CTLA-4 antibody generated using NEObody technology, which is in phase 1b/2 clinical trials to treat advanced/metastatic solid tumors; ADG206, which is in phase 1 clinical development to treat advanced metastatic solid tumors; ADG104, anti-PD-L1 monoclonal antibody which is in phase 2 clinical development; and ADG125, a novel anti-CSF-1R mAb which is in Phase 2 clinical development. In addition, it is developing ADG138, a HER2xCD3 POWERbody which is in pre clinical trial to treat low expressing tumors, as well as resistant/refractory tumors; ADG152, a CD20xCD3 POWERbody which is in preclincal trial to treat off-tumor toxicities; ADG153, a masked anti-CD47 IgG1 SAFEbody, wihx is in preclinical trial for the treatment of hematologic and solid tumor; and CD28 T-cell engagers, an anti-CD28 bispecific POWERbody TCEs to treat solid tumors. The company was incorporated in 2011 and is headquartered in Suzhou, China.

Organization	Adagene-adr
Employees	138
CEO	Dr. Peter P. Luo Ph.D.
Industry	Healthcare

Management People of Adagene-adr

Name	Title
Dr. Peter P. Luo Ph.D.	Co- Founder, Chairman, CEO and President of R&D
Mr. Man Kin Tam M.B.A.	CFO & Director
Ms. Ling Zhou	Executive Director & Head of Human Resources
Dr. Qinghai Zhao Ph.D.	Chief Manufacturing Officer
Ms. Yan Li M.B.A.	Senior Vice President of Bioinformatics & Information Technology
Ms. Xiaohong She	Senior VP & Head of Clinical Operations
Dr. Guizhong Liu Ph.D.	Senior Vice President of Early Drug Discovery
Mr. Alexander Goergen	VP & Head of Business Development
Dr. Jiping Zha M.D., Ph.D.	Executive Vice President of Clinical Development
Dr. Songmao Zheng Ph.D.	Senior VP of Clinical Pharmacology & Quantitative Sciences

Important FAQs about investing in ADAG Stock from India :

What is Adagene-adr share price today?

Adagene-adr share price today stands at $1.55, Open: $1.60 ; Previous Close: $1.58 ; High: $1.60 ; Low: $1.55 ; 52 Week High: $3.58 ; 52 Week Low: $1.33.

The stock opens at $1.60, after a previous close of $1.58. The stock reached a daily high of $1.60 and a low of $1.55, with a 52-week high of $3.58 and a 52-week low of $1.33.

Can Indians buy Adagene-adr shares?

Yes, Indians can invest in the Adagene-adr (ADAG) from India.

With INDmoney, you can buy Adagene-adr at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Adagene-adr at zero transaction cost.

How can I buy Adagene-adr shares from India?

It is very easy to buy Adagene-adr from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Adagene-adr (ADAG) be purchased?

Yes, you can buy fractional shares of Adagene-adr with INDmoney app.

What are the documents required to start investing in Adagene-adr stocks?

To start investing in Adagene-adr, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.